To test the hypothesis that PAH involves alteration of glutamine metabolism, we quantified fasting serum glutamine levels in heritable PAH patients with known BMPR2 mutations, in unaffected mutation carriers (individuals with known BMPR2 mutations but no evidence of PAH), and in married-in controls from the same households as patients and carriers. Here, BMPR2 is linked to pulmonary arterial hypertension.